Stage III Melanoma

Also known as: Stage 3 Melanoma / Clinical Stage III Cutaneous Melanoma AJCC v8

DrugDrug NameDrug Description
DB09037PembrolizumabA PD-1 blocking antibody used to treat various types of cancer, including metastatic melanoma, non small-cell lung cancer, cervical cancer, head and neck cancer, and Hodgkin's lymphoma.
DB08911TrametinibA kinase inhibitor used alone or in combination with dabrafenib to treat patients with cancers with specific BRAF mutations, such as melanoma and non-small cell lung cancer.
DrugDrug NamePhaseStatusCount
DB11967Binimetinib0Recruiting1
DB11718Encorafenib0Recruiting1
DB06186Ipilimumab0Recruiting1
DB09035Nivolumab0Recruiting2
DB14851Relatlimab0Recruiting1
DB025942'-Deoxycytidine1Completed1
DB00041Aldesleukin1Not Yet Recruiting1
DB12442Alvespimycin1Completed1
DB01143Amifostine1Completed1
DB00928Azacitidine1Completed1
DB00531Cyclophosphamide1Not Yet Recruiting1
DB01262Decitabine1Completed1
DB16150Eftilagimod alfa1Completed1
DB01073Fludarabine1Not Yet Recruiting1
DB00105Interferon alfa-2b1Completed1
DB14123Menthol1Completed1
DB09037Pembrolizumab1Completed1
DB09037Pembrolizumab1Recruiting1
DB00398Sorafenib1Completed1
DB17370TBX-34001Recruiting1
DB06287Temsirolimus1Completed1
DB00041Aldesleukin1 / 2Terminated1
DB00112Bevacizumab1 / 2Completed1
DB00004Denileukin diftitox1 / 2Terminated1
DB06643Denosumab1 / 2Active Not Recruiting1
DB00619Imatinib1 / 2Completed1
DB12827Indoximod1 / 2Completed1
DB06186Ipilimumab1 / 2Active Not Recruiting1
DB06186Ipilimumab1 / 2Completed1
DB09035Nivolumab1 / 2Active Not Recruiting1
DB09035Nivolumab1 / 2Completed1
DB09035Nivolumab1 / 2Terminated1
DB09037Pembrolizumab1 / 2Active Not Recruiting1
DB09037Pembrolizumab1 / 2Completed1
DB00755Tretinoin1 / 2Active Not Recruiting1
DB08885Aflibercept2Completed1
DB00041Aldesleukin2Recruiting1
DB17439Allovectin-72Completed1
DB18177BNT1112Active Not Recruiting1
DB11967Binimetinib2Recruiting2
DB14707Cemiplimab2Active Not Recruiting1
DB11890Cilengitide2Terminated1
DB16372Cobolimab2Recruiting1
DB08912Dabrafenib2Completed2
DB00851Dacarbazine2Completed1
DB17157Darleukin2Active Not Recruiting1
DB06643Denosumab2Completed1
DB15627Dostarlimab2Recruiting1
DB11718Encorafenib2Recruiting1
DB06205Hyaluronidase (human recombinant)2Active Not Recruiting1
DB00619Imatinib2Recruiting1
DB00065Infliximab2Recruiting1
DB06186Ipilimumab2Active Not Recruiting1
DB06186Ipilimumab2Completed1
DB06186Ipilimumab2Recruiting3
DB06186Ipilimumab2Withdrawn1
DB09078Lenvatinib2Active Not Recruiting1
DB14986Linrodostat2Withdrawn1
DB14123Menthol2Withdrawn1
DB00959Methylprednisolone2Recruiting1
DB14644Methylprednisolone hemisuccinate2Recruiting1
DB04868Nilotinib2Unknown Status1
DB09035Nivolumab2Active Not Recruiting2
DB09035Nivolumab2Completed1
DB09035Nivolumab2Recruiting3
DB09035Nivolumab2Withdrawn1
DB06650Ofatumumab2Completed1
DB16269Onfekafusp alfa2Active Not Recruiting1
DB01229Paclitaxel2Completed1
DB06589Pazopanib2Completed1
DB09037Pembrolizumab2Active Not Recruiting2
DB09037Pembrolizumab2Completed2
DB09037Pembrolizumab2Recruiting1
DB09037Pembrolizumab2Withdrawn1
DB00635Prednisone2Recruiting1
DB08896Regorafenib2Recruiting1
DB00073Rituximab2Active Not Recruiting1
DB18439SCIB12Recruiting1
DB00020Sargramostim2Completed1
DB00020Sargramostim2Withdrawn1
DB00398Sorafenib2Completed1
DB00398Sorafenib2Withdrawn1
DB18672Suratadenoturev2Unknown Status1
DB13896Talimogene laherparepvec2Active Not Recruiting1
DB06398Tanespimycin2Terminated1
DB00853Temozolomide2Not Yet Recruiting1
DB06287Temsirolimus2Withdrawn1
DB15043Toripalimab2Not Yet Recruiting1
DB08911Trametinib2Completed2
DB17439Allovectin-73Completed1
DB15140Bempegaldesleukin3Terminated1
DB00851Dacarbazine3Completed1
DB17329Eltrapuldencel-T3Terminated1
DB01042Melphalan3Completed1
DB09035Nivolumab3Terminated1
DB16740Prolgolimab3Recruiting2
DB11967BinimetinibNot AvailableRecruiting1
DB08912DabrafenibNot AvailableRecruiting1
DB11718EncorafenibNot AvailableRecruiting1
DB09035NivolumabNot AvailableRecruiting1
DB08911TrametinibNot AvailableRecruiting1